Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, et al.
Nanomaterials (2020) Vol. 10, Iss. 2, pp. 364-364
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov, Robert E. Bird, Allison Curtze, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 16982-17015
Closed Access | Times Cited: 1324
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 817-838
Open Access | Times Cited: 969
Nanomaterial Delivery Systems for mRNA Vaccines
Michael D. Buschmann, Manuel Carrasco, Suman Alishetty, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 65-65
Open Access | Times Cited: 453
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 403
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
María L. Guevara, Francesca Persano, Stefano Persano
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 200
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 16-40
Open Access | Times Cited: 200
Paving the Road for RNA Therapeutics
Niels Dammes, Dan Peer
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 10, pp. 755-775
Open Access | Times Cited: 188
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
Basmah N. Aldosari, Iman M. Alfagih, Alanood S. Almurshedi
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 206-206
Open Access | Times Cited: 174
The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA
Pratikkumar Patel, Nurudeen Mohammed Ibrahim, Kun Cheng
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 6, pp. 448-460
Open Access | Times Cited: 161
A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems
Meredith Packer, Dipendra Gyawali, Ravikiran Yerabolu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 147
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
Pardis Kazemian, Si-Yue Yu, Sarah B. Thomson, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 6, pp. 1669-1686
Open Access | Times Cited: 144
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 113
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 101
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 77
The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments
Janet M. Sasso, Barbara J. B. Ambrose, Rumiana Tenchov, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 6975-7015
Open Access | Times Cited: 73
mRNA in the Context of Protein Replacement Therapy
Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 166-166
Open Access | Times Cited: 64
Biologics, theranostics, and personalized medicine in drug delivery systems
Matteo Puccetti, Marilena Pariano, Aurélie Schoubben, et al.
Pharmacological Research (2024) Vol. 201, pp. 107086-107086
Open Access | Times Cited: 64
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 61
Messenger RNA therapy for rare genetic metabolic diseases
Pedro Berraondo, Paolo G.V. Martini, Matías A. Ávila, et al.
Gut (2019) Vol. 68, Iss. 7, pp. 1323-1330
Open Access | Times Cited: 95
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
Tina Briolay, Tacien Petithomme, Morgane Fouet, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 88
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
An‐Katrien Minnaert, Helena Vanluchene, R Verbeke, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113900-113900
Open Access | Times Cited: 88
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
Hamideh Parhiz, Jacob S. Brenner, Priyal Patel, et al.
Journal of Controlled Release (2021) Vol. 344, pp. 50-61
Open Access | Times Cited: 87
Advances in mRNA non-viral delivery approaches
Maria L. Ibba, Giuseppe Ciccone, Carla Lucia Esposito, et al.
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113930-113930
Closed Access | Times Cited: 80
The influence of nanoparticulate drug delivery systems in drug therapy
Nafiu Aminu, Idris Bello, Nura Muhammad Umar, et al.
Journal of Drug Delivery Science and Technology (2020) Vol. 60, pp. 101961-101961
Closed Access | Times Cited: 73
Page 1 - Next Page

Scroll to top